Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds Vivasclinical-pharmacology-and-therapeutics

Paeds Vivas · clinical-pharmacology-and-therapeutics

Inhaled therapies and device selection — branching viva

Branching viva on inhaled therapies and device selection in children: choosing the device by the age-based ladder, defending why a spacer is essential for pressurised-inhaler delivery, applying the spacer-versus-nebuliser evidence in acute asthma, and resolving a 'failing' inhaled corticosteroid by correcting the device and technique before escalating the dose.

branching clinical structured oral4 min readVerification in progress

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
On this page
Study tools

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
A clinic referral about an eighteen-month-old with viral wheeze prescribed a salbutamol pressurised inhaler with no spacer. The examiner asks you to state the correct device for the age, why a spacer is essential, and how you would teach the family — then branches to a six-year-old with acute asthma where you must defend the spacer-versus-nebuliser choice, and finally to a nine-year-old whose inhaled corticosteroid 'isn't working', forcing the device-and-technique assessment before any dose escalation.

Opening — the eighteen-month-old with no spacer

Examiner: An eighteen-month-old with viral wheeze has been prescribed a salbutamol pressurised inhaler with no spacer. What is the correct device, and why is the spacer essential? [1] [8]

Candidate (model): The correct device for this age is a pressurised metered-dose inhaler seated in a small-volume valved holding chamber with a tightly-fitting face mask. The spacer is essential because a pressurised inhaler fires its aerosol cloud in under a tenth of a second at high velocity — far too fast for an infant to time to a single breath — so without a spacer most of the dose deposits in the oropharynx and almost nothing reaches the lung. The spacer intercepts the fast cloud, slows and suspends it, so the infant can clear it by slow tidal breathing over around six breaths, with the mask sealed firmly to the face. A dry-powder inhaler would not work at this age because the child cannot generate the inspiratory flow. [1] [8]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References4ShowHide
  1. [1]Dolovich MB, Ahrens RC, Hess DR, et al. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest, 2005.PMID 15654001
  2. [3]van Aalderen WM, Garcia-Marcos L, Gappa M, et al. How to match the optimal currently available inhaler device to an individual child with asthma or recurrent wheeze. NPJ Primary Care Respiratory Medicine, 2015.PMID 25568979
  3. [5]Cates CJ, Welsh EJ, Rowe BH Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database of Systematic Reviews, 2013.PMID 24037768
  4. [8]Amirav I, Newhouse MT Aerosol therapy in infants and toddlers: past, present and future. Expert Review of Respiratory Medicine, 2008.PMID 20477295
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousImmunosuppressive and biologic therapies — branching vivaclinical-pharmacology-and-therapeuticsNextMedication adherence and formulation challenges — branching vivaclinical-pharmacology-and-therapeutics